Vision rehabilitation of post-Descemet membrane endothelial keratoplasty Pseudomonas keratitis utilizing losartan ophthalmic solution and scleral contact lens: a case report

氯沙坦滴眼液联合巩膜接触镜治疗Descemet膜内皮角膜移植术后铜绿假单胞菌性角膜炎的视力康复:病例报告

阅读:1

Abstract

BACKGROUND: Descemet membrane endothelial keratoplasty is a preferred treatment for endothelial dysfunction, but complications, such as graft detachment and Pseudomonas keratitis, may affect results. Managing post-keratoplasty infectious keratitis poses unique challenges, with incidence varying by keratoplasty type. Diagnosis typically requires corneal scraping, and treatment strategies encompass broad-spectrum antimicrobials and surgical procedures. CASE PRESENTATION: This current case study examines the treatment of Pseudomonas keratitis in a 76-year-old Jewish male patient following Descemet membrane endothelial keratoplasty, exacerbated by freshwater exposure, in the left eye. Despite initial complications such as graft detachment, a comprehensive treatment plan, including the use of losartan 0.8 mg/mL ophthalmic solution for 7 months, followed by the fitting of a custom scleral toric contact lens, alleviated ocular surface symptoms and quality of vision (by questionnaires). The scleral contact lens provided excellent centration, and the patient's best correction visual acuity enhanced from 0.9 logMAR to 0.2 logMAR, and his near best correction visual acuity improved from Jaeger 13 to Jaeger 3.0 with +2.50 D reading spectacles worn over the scleral contact lens. Additionally, the patient's 10% low-contrast distance best correction visual acuity in the left eye enhanced from 1.3 logMAR to 0.47 (-1) logMAR in photopic conditions when using the scleral contact lens. Patient data were collected after written informed consent. CONCLUSIONS: The present report emphasizes the efficacy of personalized therapeutic strategies in the postoperative management of Descemet membrane endothelial keratoplasty patients, highlighting innovative pharmacological approaches and customized scleral contact lenses in addressing complications and enhancing patient outcomes.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。